Researchers discover a new way to reduce implant rejection

The team from the University of Nottingham's Schools of Pharmacy and Life Sciences have found that the surface shape (topography) and chemical composition of polymer materials can be changed to create materials that control the body's immune response.

This could have future applications in the fight against rejection of medical devices including artificial joints, dental implants and vascular implants. The results from two recent studies have been published in Advanced Science and Matter.

Artificial joints, stents and dental implants are among the most common devices that use biomaterials to restore function or completely replace diseased or damaged tissues.

However, following the implantation of biomaterials in the body, a host reaction is common, including responses such as inflammation, a foreign body reaction (FBR), and fibrous capsule development which can result in the implant failing.

These reactions are driven by the activation of immune cells called monocytes and macrophages attaching to the implant surface. The physical features on the surface of a material or implant known as 'topography' is known to influence macrophage attachment.

Professor Amir Ghaemmaghami has co-led the research, he explains:

We are looking at ways to create materials that can be safely put inside the body without the immune system attacking it and causing rejection. To do this we are exploring materials that can control the immune response.

We have used high throughput screening technology to examine how the topography and chemical properties of a material can be used to design "immune?instructive" surfaces for potential use in implants, which influence macrophage function and consequently the foreign body responses to biomaterials."

Taking control of the immune response

A state-of-the-art high throughput screening approach was used to investigate the relationship between material topographies and immune cell attachment and behaviours for 2176 different micropatterns.

The results indicated that micron-scale pillars 5-10um in diameter were key in driving macrophage attachment, and that the density of the micropillars proved key in controlling inflammatory reactions.

The team also discovered immune instructive polymer chemistries that successfully controlled the immune response in a pre-clinical rodent model. This was achieved through screening libraries of diverse polymers and identifying materials that control the behaviour of macrophages.

An AI algorithm was used to model the relationships between the material chemistries and the cell responses they produced. These results suggest that different immune-instructive polymers attract different amounts of protein adsorption which was key to the macrophage responses.

Professor Morgan Alexander also co-led the research, he said:

These latest discoveries add to a wealth of materials research taking place at the University of Nottingham and it is exciting to have discovered these biomaterials that could be a real game-changer in the area of medical implants.

Getting these materials used in a commercial product would be our ultimate aim for this research, there is still a way to go to get there but these discoveries are a significant step towards that."

Source:
Journal reference:

Rostam, H. M., et al. (2020) Immune-Instructive Polymers ControlMacrophage Phenotype and Modulate the Foreign Body Response In Vivo. Matter. doi.org/10.1016/j.matt.2020.03.018.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Future directions and challenges in harnessing NK cells against Acute Myeloid Leukemia